DARPP-32:ドーパミナージック神経伝送の有効性を調節する
A A Fienberg1, N Hiroi, P G Mermelstein
1Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10021, USA.
まとめ
DARPP-32は,脳内のドーパミンシグナル伝達に不可欠です. このタンパク質が欠けていたマウスは,ドーパミンに対する反応の有意な欠乏を示し,ドーパミン作用神経伝達を調節する中心的な役割を示した.
科学分野:
- 神経科学は神経科学である.
- 分子生物学は分子生物学である.
- 薬理学 薬理学とは
背景:
- ドーパミナージックニューロンは前頭脳の活動を調節する.
- DARPP-32は,ドーパミナージックインプットを受信するニューロンに存在します.
- ドーパミンは,DARPP-32をタンパク質フォスファターゼ阻害剤に変換する.
研究 の 目的:
- ドーパミン神経伝達におけるDARPP-32の役割を調査する.
- DARPP-32欠乏が神経応答に与える影響を理解するために.
主な方法:
- 遺伝子ターゲティングにより,DARPP-32のノックアウトマウスを生み出す.
- 分子,電気生理学,および行動反応の評価.
主要な成果:
- DARPP-32のノックアウトマウスは深刻な欠陥を示した.
- これらの欠陥は,ドーパミン,乱用薬,抗精神病薬に対する反応で観察されました.
- この研究は,DARPP-32.2の重要な機能を強調しています.
結論:
- DARPP-32は,ドーパミナージック神経伝送の有効性にとって不可欠です.
- ドーパミンおよび関連薬に対する反応を媒介する中心的な役割を果たします.
関連する概念動画
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...


